In this briefing, we present an overview of a new organisation called Biosafety South Africa. Biosafety South Africa was launched early this year, receives funding from the South African government through the Department of Science and Technology. Biosafety South Africa has no legislative mandate to influence GMO decision making but appears set to carve its niche in the arena of assisting GMO permit applicants in the preparation of their applications.
The privatisation of Publically Funded Research in South Africa; Lessons from the US Bayh-Dole experience
In this paper, we present an overview of South Africa‘s Intellectual Property Rights from Publicly funded research and development Act, which imitates the US Bayh-Dole Act. The paper draws on the experience of the Bahy-Dole legislation in the US to show the shortcomings of the common approach aimed at facilitating the transfer of innovative research from the public to the private sector by way of IRP protection including patents. In the US, the Bayh-Dole has dramatically changed the nature of publicly financed institutions from those conducting pure research to quasi commercial entities withholding information in the quest for patent protection.
By Michelle Misaki Koyama